ALPINE IMMUNE SCIENCES, INC. Operating Expenses
ALPINE IMMUNE SCIENCES, INC. reported Operating Expenses of $29.73 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2024-05-09
- ALPINE IMMUNE SCIENCES, INC. operating expenses for the quarter ending 2024-03-31 was $29.73M, a 19.01% increase year-over-year.
- ALPINE IMMUNE SCIENCES, INC. operating expenses for the quarter ending 2023-12-31 was $29.31M, a 26.62% increase year-over-year.
- ALPINE IMMUNE SCIENCES, INC. operating expenses for the quarter ending 2023-09-30 was $24.59M, a 10.78% increase year-over-year.
- ALPINE IMMUNE SCIENCES, INC. operating expenses for the quarter ending 2023-06-30 was $24.25M, a 11.33% increase year-over-year.
- ALPINE IMMUNE SCIENCES, INC. operating expenses for fiscal 2023 was $103.13M, a 16.91% increase from fiscal 2022.
- ALPINE IMMUNE SCIENCES, INC. operating expenses for fiscal 2022 was $88.21M, a 20.34% increase from fiscal 2021.
- ALPINE IMMUNE SCIENCES, INC. operating expenses for fiscal 2021 was $73.30M, a 92.47% increase from fiscal 2020.
- ALPINE IMMUNE SCIENCES, INC. operating expenses for fiscal 2020 was $38.08M, a 15.96% decline from fiscal 2019.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2024-03-31 | $29.73M 10-Q · filed 2024-05-09 | $59.03M derived: sum of 2 quarters · filed 2024-05-09 | $83.63M derived: sum of 3 quarters · filed 2024-05-09 | $107.88M derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | $29.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $53.90M derived: sum of 2 quarters · filed 2024-03-20 | $78.15M derived: sum of 3 quarters · filed 2024-03-20 | $103.13M 10-K · filed 2024-03-20 |
| 2023-09-30 | $24.59M 10-Q · filed 2023-11-14 | $48.84M derived: sum of 2 quarters · filed 2023-11-14 | $73.82M 10-Q · filed 2023-11-14 | $96.97M derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-06-30 | $24.25M 10-Q · filed 2023-08-14 | $49.23M 10-Q · filed 2023-08-14 | $72.37M derived: sum of 3 quarters · filed 2024-05-09 | $94.57M derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-03-31 | $24.98M 10-Q · filed 2024-05-09 | $48.12M derived: sum of 2 quarters · filed 2024-05-09 | $70.32M derived: sum of 3 quarters · filed 2024-05-09 | $92.10M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $23.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $45.34M derived: sum of 2 quarters · filed 2024-03-20 | $67.13M derived: sum of 3 quarters · filed 2024-03-20 | $88.21M 10-K · filed 2024-03-20 |
| 2022-09-30 | $22.20M 10-Q · filed 2023-11-14 | $43.98M derived: sum of 2 quarters · filed 2023-11-14 | $65.07M 10-Q · filed 2023-11-14 | $84.97M derived: sum of 4 quarters · filed 2024-03-20 |
| 2022-06-30 | $21.78M 10-Q · filed 2023-08-14 | $42.87M 10-Q · filed 2023-08-14 | $62.77M derived: sum of 3 quarters · filed 2024-03-20 | $84.55M derived: sum of 4 quarters · filed 2024-03-20 |
| 2022-03-31 | $21.09M 10-Q · filed 2023-05-11 | $40.99M derived: sum of 2 quarters · filed 2024-03-20 | $62.77M derived: sum of 3 quarters · filed 2024-03-20 | $80.69M derived: sum of 4 quarters · filed 2024-03-20 |
| 2021-12-31 | $19.91M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $41.69M derived: sum of 2 quarters · filed 2024-03-20 | $59.61M derived: sum of 3 quarters · filed 2024-03-20 | $73.30M 10-K · filed 2024-03-20 |
| 2021-09-30 | $21.78M 10-Q · filed 2022-11-14 | $39.70M derived: sum of 2 quarters · filed 2022-11-14 | $53.40M 10-Q · filed 2022-11-14 | $65.50M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | $17.92M 10-Q · filed 2022-08-11 | $31.62M 10-Q · filed 2022-08-11 | $43.72M derived: sum of 3 quarters · filed 2023-03-23 | $52.60M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | $13.69M 10-Q · filed 2022-05-12 | $25.80M derived: sum of 2 quarters · filed 2023-03-23 | $34.68M derived: sum of 3 quarters · filed 2023-03-23 | $45.12M derived: sum of 4 quarters · filed 2023-03-23 |
| 2020-12-31 | $12.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $20.99M derived: sum of 2 quarters · filed 2023-03-23 | $31.43M derived: sum of 3 quarters · filed 2023-03-23 | $38.08M 10-K · filed 2023-03-23 |
| 2020-09-30 | $8.88M 10-Q · filed 2021-11-10 | $19.32M derived: sum of 2 quarters · filed 2021-11-10 | $25.98M 10-Q · filed 2021-11-10 | $33.88M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-06-30 | $10.44M 10-Q · filed 2021-08-10 | $17.10M 10-Q · filed 2021-08-10 | $25.00M derived: sum of 3 quarters · filed 2022-03-17 | $37.00M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-03-31 | $6.66M 10-Q · filed 2021-05-13 | $14.56M derived: sum of 2 quarters · filed 2022-03-17 | $26.56M derived: sum of 3 quarters · filed 2022-03-17 | $39.27M derived: sum of 4 quarters · filed 2022-03-17 |
| 2019-12-31 | $7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $19.90M derived: sum of 2 quarters · filed 2022-03-17 | $32.62M derived: sum of 3 quarters · filed 2022-03-17 | $45.31M 10-K · filed 2022-03-17 |
| 2019-09-30 | $12.00M 10-Q · filed 2020-11-12 | $24.72M derived: sum of 2 quarters · filed 2020-11-12 | $37.41M 10-Q · filed 2020-11-12 | $48.86M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-06-30 | $12.72M 10-Q · filed 2020-08-11 | $25.41M 10-Q · filed 2020-08-11 | $36.86M derived: sum of 3 quarters · filed 2021-03-18 | $49.24M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-03-31 | $12.70M 10-Q · filed 2020-05-14 | $24.14M derived: sum of 2 quarters · filed 2021-03-18 | $36.53M derived: sum of 3 quarters · filed 2021-03-18 | $45.33M derived: sum of 4 quarters · filed 2021-03-18 |
| 2018-12-31 | $11.45M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $23.83M derived: sum of 2 quarters · filed 2021-03-18 | $32.63M derived: sum of 3 quarters · filed 2021-03-18 | $38.53M 10-K · filed 2021-03-18 |
| 2018-09-30 | $12.39M 10-Q · filed 2019-11-14 | $21.19M derived: sum of 2 quarters · filed 2019-11-14 | $27.09M 10-Q · filed 2019-11-14 | $32.01M derived: sum of 4 quarters · filed 2020-03-30 |
| 2018-06-30 | $8.80M 10-Q · filed 2019-08-13 | $14.70M 10-Q · filed 2019-08-13 | $19.62M derived: sum of 3 quarters · filed 2020-03-30 | $24.30M derived: sum of 4 quarters · filed 2020-03-30 |
| 2018-03-31 | $5.90M 10-Q · filed 2019-05-09 | $10.82M derived: sum of 2 quarters · filed 2020-03-30 | $15.50M derived: sum of 3 quarters · filed 2020-03-30 | $19.87M derived: sum of 4 quarters · filed 2020-03-30 |
| 2017-12-31 | $4.92M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $9.60M derived: sum of 2 quarters · filed 2020-03-30 | $13.97M derived: sum of 3 quarters · filed 2020-03-30 | $16.70M 10-K · filed 2020-03-30 |
| 2017-09-30 | $4.68M 10-Q · filed 2018-11-08 | $9.06M derived: sum of 2 quarters · filed 2018-11-08 | $11.79M 10-Q · filed 2018-11-08 | $13.51M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | $4.38M 10-Q · filed 2018-08-09 | $7.11M 10-Q · filed 2018-08-09 | $8.83M derived: sum of 3 quarters · filed 2019-03-18 | $9.95M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | $2.73M 10-Q · filed 2018-05-14 | $4.46M derived: sum of 2 quarters · filed 2019-03-18 | $5.57M derived: sum of 3 quarters · filed 2019-03-18 | |
| 2016-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $2.84M derived: sum of 2 quarters · filed 2019-03-18 | $4.14M 10-K · filed 2019-03-18 | |
| 2016-09-30 | $1.12M 10-Q · filed 2017-11-14 | $2.41M 10-Q · filed 2017-11-14 | ||
| 2015-12-31 | $863.00K 10-K · filed 2018-03-28 |